Actrapid vs Actrapid Innolet: Side-by-Side Comparison
Quick answer: Actrapid and Actrapid Innolet are both short-acting human insulin used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Actrapid | Actrapid Innolet |
|---|---|---|
| Drug class | Short-acting human insulin | Short-acting human insulin |
| ATC code | A10AB01 | A10AB01 |
| Primary indications | Type 1 diabetes mellitus, Type 2 diabetes mellitus | Diabetes mellitus type 1, Diabetes mellitus type 2 |
| Mechanism | Soluble recombinant human insulin binding insulin receptors to facilitate glucose uptake | Recombinant human insulin that binds insulin receptors to lower blood glucose by promoting cellular glucose uptake |
| Common dose | 0.3-1 IU/kg/day SC in divided doses | Individualized; typically 0.3-1 IU/kg/day subcutaneously |
| Detail page | Actrapid details → | Actrapid Innolet details → |
How to choose between Actrapid and Actrapid Innolet
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Short-acting human insulin on iMedic · Actrapid full details · Actrapid Innolet full details
Frequently asked questions
Is Actrapid better than Actrapid Innolet?
Neither is universally 'better.' They are both short-acting human insulin with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Actrapid to Actrapid Innolet?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Actrapid and Actrapid Innolet have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Actrapid and Actrapid Innolet available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.